<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Journal of Natural Sciences Research</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Journal of Natural Sciences Research</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Журнал естественнонаучных исследований</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2500-0489</issn>
   <issn publication-format="online">2500-0489</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">94560</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>Медицинские науки</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>MEDICINE SCIENCE</subject>
    </subj-group>
    <subj-group>
     <subject>Медицинские науки</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">Pathogenetic basis of topical corticosteroids and calcineurin inhibitors action, side effects and morphologic changes in the dermis.</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Патогенетические основы действия топических кортикостероидов и ингибиторов кальциневрина, побочные эффекты и морфологические изменения в дерме.</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Шарапатюк</surname>
       <given-names>В. Д.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Sharapatyuk</surname>
       <given-names>Valentina Dmitrievna</given-names>
      </name>
     </name-alternatives>
     <email>valentina.sh0503@gmail.com</email>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Чагина</surname>
       <given-names>Е. А.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Chagina</surname>
       <given-names>Evgenia Aleksandrovna</given-names>
      </name>
     </name-alternatives>
     <email>echagina@mail.ru</email>
     <bio xml:lang="ru">
      <p>кандидат медицинских наук;кандидат медицинских наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>candidate of medical sciences;candidate of medical sciences;</p>
     </bio>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Тихоокеанский государственный медицинский университет</institution>
    </aff>
    <aff>
     <institution xml:lang="en">Pacific State Medical University</institution>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Тихоокеанский государственный медицинский университет</institution>
     <city>Владивосток</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Тихоокеанский государственный медицинский университет</institution>
     <city>Владивосток</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2025-02-24T22:47:54+03:00">
    <day>24</day>
    <month>02</month>
    <year>2025</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-02-24T22:47:54+03:00">
    <day>24</day>
    <month>02</month>
    <year>2025</year>
   </pub-date>
   <volume>10</volume>
   <issue>1</issue>
   <fpage>27</fpage>
   <lpage>32</lpage>
   <history>
    <date date-type="received" iso-8601-date="2025-02-03T00:00:00+03:00">
     <day>03</day>
     <month>02</month>
     <year>2025</year>
    </date>
   </history>
   <self-uri xlink:href="https://naukaru.ru/en/nauka/article/94560/view">https://naukaru.ru/en/nauka/article/94560/view</self-uri>
   <abstract xml:lang="ru">
    <p>В статье описана значимость топических кортикостероидов и топических ингибиторов кальциневрина в современной медицине, раскрываются механизмы их действия на клеточном и организменном уровне, патогенетические аспекты, а также связанные с ним побочные эффекты. В данной работе дается аналитическая оценка публикационной активности по обеим группам препаратов с использованием русскоязычных и иностранных ресурсов в период с 2019 по 2024 годы. Прослеживается постепенное увеличение числа публикаций с упоминанием топических ингибиторов кальциневрина и постепенное снижение количества статей с упоминанием топических глюкокортикоидов.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>The article presents the significance of topical corticosteroids and topical calcineurin inhibitors in modern medicine, reveals the mechanisms of their action at the cellular and system level, pathogenetic aspects and associated side effects. This paper provides an analytical assessment of publication activity on both groups of drugs using Russian-language and foreign resources in the period from 2019 to 2024. A gradual increase in the number of publications mentioning topical calcineurin inhibitors and a slow decrease in the number of articles mentioning topical glucocorticoids are traced.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>топические кортикостероиды</kwd>
    <kwd>топические ингибиторы кальциневрина</kwd>
    <kwd>глюкокортикостероиды</kwd>
    <kwd>топические препараты</kwd>
    <kwd>стероидчувствительные дерматозы</kwd>
    <kwd>побочные эффекты</kwd>
    <kwd>кожа</kwd>
    <kwd>структурные изменения</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>topical corticosteroids</kwd>
    <kwd>topical calcineurin inhibitors</kwd>
    <kwd>glucocorticosteroids</kwd>
    <kwd>topical drugs</kwd>
    <kwd>steroid-sensitive dermatoses</kwd>
    <kwd>side effects</kwd>
    <kwd>skin</kwd>
    <kwd>structural changes</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rathi S.K., D'Souza P. Rational and ethical use of topical corticosteroids based on safety and efficacy // Indian Journal of Dermatology. -2012; -Vol. 57. -№ 4. -P. 251-259. https://doi.org/10.4103/0019-5154.97655</mixed-citation>
     <mixed-citation xml:lang="en">Rathi S.K., D'Souza P. Rational and ethical use of topical corticosteroids based on safety and efficacy // Indian Journal of Dermatology. -2012; -Vol. 57. -№ 4. -P. 251-259. https://doi.org/10.4103/0019-5154.97655</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Charman C.R., Morris A.D., Williams H.C. Topical corticosteroid phobia in patients with atopic eczema // British Journal of Dermatology. -2000. -Vol. 142. -№ 5. -P. 931–936. https://doi.org/10.1046/j.1365-2133.2000.03473.x</mixed-citation>
     <mixed-citation xml:lang="en">Charman C.R., Morris A.D., Williams H.C. Topical corticosteroid phobia in patients with atopic eczema // British Journal of Dermatology. -2000. -Vol. 142. -№ 5. -P. 931–936. https://doi.org/10.1046/j.1365-2133.2000.03473.x</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Tan S.Y., Chandran N.S., Choi, E.CE. Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal // Clinical Drug Investigation. -2021. -Vol. 41. -P. 835–842. https://doi.org/10.1007/s40261-021-01072-z</mixed-citation>
     <mixed-citation xml:lang="en">Tan S.Y., Chandran N.S., Choi, E.CE. Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal // Clinical Drug Investigation. -2021. -Vol. 41. -P. 835–842. https://doi.org/10.1007/s40261-021-01072-z</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Siegfried E.C., Jaworski J.C., Hebert A.A. Topical Calcineurin Inhibitors and Lymphoma Risk: Evidence Update with Implications for Daily Practice // American Journal of Clinical Dermatology. -2013. -Vol. 14. -P. 163–178. https://doi.org/10.1007/s40257-013-0020-1</mixed-citation>
     <mixed-citation xml:lang="en">Siegfried E.C., Jaworski J.C., Hebert A.A. Topical Calcineurin Inhibitors and Lymphoma Risk: Evidence Update with Implications for Daily Practice // American Journal of Clinical Dermatology. -2013. -Vol. 14. -P. 163–178. https://doi.org/10.1007/s40257-013-0020-1</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Eichenfield, L.F. et al. Guidelines of care for the management of atopic dermatitis // Journal of the American Academy of Dermatology. -2014. -Vol. 71. - № 1. -P. 116 – 132. https://doi.org/10.1016/j.jaad.2014.03.023</mixed-citation>
     <mixed-citation xml:lang="en">Eichenfield, L.F. et al. Guidelines of care for the management of atopic dermatitis // Journal of the American Academy of Dermatology. -2014. -Vol. 71. - № 1. -P. 116 – 132. https://doi.org/10.1016/j.jaad.2014.03.023</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Niculet E., Bobeica C., Tatu A. L. Glucocorticoid-Induced Skin Atrophy: The Old and the New // Clinical, Cosmetic and Investigational Dermatology. -2020, -Vol. 13. -P. 1041–1050. https://doi.org/10.2147/CCID.S224211</mixed-citation>
     <mixed-citation xml:lang="en">Niculet E., Bobeica C., Tatu A. L. Glucocorticoid-Induced Skin Atrophy: The Old and the New // Clinical, Cosmetic and Investigational Dermatology. -2020, -Vol. 13. -P. 1041–1050. https://doi.org/10.2147/CCID.S224211</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Uva L., Miguel D., Pinheiro C., Antunes J., Cruz D., Ferreira J., Filipe P. Mechanisms of action of topical corticosteroids in psoriasis // International Journal of Endocrinology. -2012. https://doi.org/10.1155/2012/561018</mixed-citation>
     <mixed-citation xml:lang="en">Uva L., Miguel D., Pinheiro C., Antunes J., Cruz D., Ferreira J., Filipe P. Mechanisms of action of topical corticosteroids in psoriasis // International Journal of Endocrinology. -2012. https://doi.org/10.1155/2012/561018</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Самцов А.В., Сухарев А.В., Патрушев А.В. Лечение атопического дерматита: преимущества такролимуса перед топическими кортикостероидами [Электронный ресурс] // Эффективная фармакотерапия. -2014. -№ 19. -С. 4–10. -URL: https://umedp.ru/upload/iblock/d92/d92ca4806a3d74318f02bdaf482fcaef.pdf</mixed-citation>
     <mixed-citation xml:lang="en">Samcov A.V., Suharev A.V., Patrushev A.V. Lechenie atopicheskogo dermatita: preimuschestva takrolimusa pered topicheskimi kortikosteroidami [Elektronnyy resurs] // Effektivnaya farmakoterapiya. -2014. -№ 19. -S. 4–10. -URL: https://umedp.ru/upload/iblock/d92/d92ca4806a3d74318f02bdaf482fcaef.pdf</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Breuer K., Werfel T., Kapp A. Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Childhood Atopic Dermatitis // American Journal of Clinical Dermatology. -2005.  -Vol. 6. -№ 2. -P. 65–77. https://doi.org/10.2165/00128071-200506020-00001</mixed-citation>
     <mixed-citation xml:lang="en">Breuer K., Werfel T., Kapp A. Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Childhood Atopic Dermatitis // American Journal of Clinical Dermatology. -2005.  -Vol. 6. -№ 2. -P. 65–77. https://doi.org/10.2165/00128071-200506020-00001</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Mehta A.B., Nadkarni N.J., Patil S.P., Godse K.V., Gautam M., Agarwal S. Topical corticosteroids in dermatology. Indian Journal of Dermatology Venereology and Leprology. -2016. -Vol. 82. -P. 371-378. https://doi.org/10.4103/0378-6323.178903</mixed-citation>
     <mixed-citation xml:lang="en">Mehta A.B., Nadkarni N.J., Patil S.P., Godse K.V., Gautam M., Agarwal S. Topical corticosteroids in dermatology. Indian Journal of Dermatology Venereology and Leprology. -2016. -Vol. 82. -P. 371-378. https://doi.org/10.4103/0378-6323.178903</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Стадникова А.С., Новик Г.А., Баграмова Г.Э., Воробьева А.С. Комплексная терапия хронических аллергодерматозов [Электронный ресурс] // Медицинский совет. -2023. -Vol. 17. -№ 2. -С. 105-112. URL: https://cyberleninka.ru/article/n/kompleksnaya-terapiya-hronicheskih-allergodermatozov (дата обращения: 03.02.2025).</mixed-citation>
     <mixed-citation xml:lang="en">Stadnikova A.S., Novik G.A., Bagramova G.E., Vorob'eva A.S. Kompleksnaya terapiya hronicheskih allergodermatozov [Elektronnyy resurs] // Medicinskiy sovet. -2023. -Vol. 17. -№ 2. -S. 105-112. URL: https://cyberleninka.ru/article/n/kompleksnaya-terapiya-hronicheskih-allergodermatozov (data obrascheniya: 03.02.2025).</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
